Direxion Daily S&P Biotech Bear 3X ETF
LABD
17 hedge funds and large institutions have $16.9M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 3 closing their positions.
227% more call options, than puts
Call options by funds: $27.2M | Put options by funds: $8.32M
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
103% more capital invested
Capital invested by funds: $8.35M → $16.9M (+$8.6M)
13.88% more ownership
Funds ownership: 14.33% → 28.21% (+14%)
6% less funds holding
Funds holding: 18 → 17 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$3.19M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.35M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$895K |
| 4 |
HF
HRT Financial
New York
|
+$419K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$418K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Cutler Group
San Francisco,
California
|
-$417K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$401K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$166K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$81K |
| 5 |
Optiver Holding
Amsterdam,
Netherlands
|
-$37.4K |
LABD Hedge Fund Activity: Q3 2021 in Review
17 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2021, worth a combined $16.9M — up 103% from $8.35M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of LABD and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 10 added.
The largest buyer was Boxer Capital, opening a new position worth an estimated $3.19M. The largest seller was Cutler Group, cutting an estimated $417K.
- 17 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2021, down from 18 in Q2 2021.
- Funds reported $16.9M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2021, up 103% quarter-over-quarter.
- 2 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2021 and 3 closed out, a net change of -1 holder.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2021 was Boxer Capital, an estimated $3.19M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2021 was Cutler Group, an estimated $417K sold.
Based on aggregated 13F filings for Q3 2021.